Amoeba Sa · EURONEXT:ALMIB
Amoeba Sa — Investor Presentation (December 2025)
23 slides from Amoeba Sa's investor presentation, December 2025
Slide 1: December 2025 | Investors Presentation
December 2025 | Investors Presentation
Slide 2: Your Contacts
Introduction Development Biocontrol Cosmetics Finance Conclusion YOUR CONTACTS A new dynamic driven by a united team with solid experience in international environments Benoit VILLERS Jean-François DOUCET Chairman of the Board of Directors CEO and Chief Financial Officer Since December 2023 Since Ma
Slide 3: A Greentech Ready to Go to Market
Introduction Development Biocontrol Cosmetics Finance Conclusion A GREENTECH READY TO GO TO MARKET Listed on Euronext Growth Amoéba Created in 2010, Amoéba is a French greentech specializing in the development of natural microbiological solutions based on the patented use of amoebas. Some figures 2
Slide 4: Recent Chronology of Amoéba
Introduction Developpement Biocontrol Cosmetics Finance Conclusion RECENT CHRONOLOGY OF AMOÉBA Change in governance at the end of 2023 and major advances since 2024 12/2023 Start of the transformation from an R&D company to an industrial and commercial enterprise A renewed governance at the end of 2
Slide 5: The Amoeba, Definition and Specific Features
Introduction Development Biocontrol Cosmetics Finance Conclusion THE AMOEBA, DEFINITION AND SPECIFIC FEATURES An amoeba Our amoeba A naturally occurring unicellular microorganism found in all Origin environmental compartments, particularly in humid W. magna C2C Maky bio sourced in Aix-les-Bains ther
Slide 6: Two Ranges with a High Level of Maturity
Introduction Development Biocontrol Cosmetics Finance Conclusion TWO RANGES WITH A HIGH LEVEL OF MATURITY Ingredient development Marketing R&D Regulatory approvals and testing Distribution agreements phases Biocontrol Approval of the active substance in the EU and the US Agreement with Koppert 9 yea
Slide 7: AXPERA
Introduction Development Biocontrol Cosmetics Finance Conclusion AXPERA A solution for the transition to sustainable agriculture is coming to market Positive impact on agriculture Market launch for 2026 Regulatory A highly competitive level of performance, Final approval of the active substance by t
Slide 8: The Ideal Solution
Introduction Development Biocontrol Cosmetics Finance Conclusion THE IDEAL SOLUTION To reduce the use of copper Efficacy on downy mildew for tomatoes Context Copper is widely used to combat mildew, but its use poses environmental problems. From 2025, European regulations will continue to reduce the
Slide 9: A Potential That Is Already Recognised
Introduction Development Biocontrol Cosmetics Finance Conclusion A POTENTIAL THAT IS ALREADY RECOGNISED Amoéba's solution is highly acclaimed by winegrowers and biocontrol stakeholders Combating downy mildew on vines in France Winner of the Bernard Blum award ➢ 15 winegrowers have used AXPERA in rea
Slide 10: Amoéba x Koppert
Introduction Development Biocontrol Cosmetics Finance Conclusion AMOÉBA x KOPPERT Signing of a major distribution agreement with a global leader in biocontrol Mutual expertise and perfect synergy €500 million in revenue, 2,750 employees, 30 subsidiaries, 20% annual growth, and distribution in more t
Slide 11: Amoéba x Syngenta
Introduction Development Biocontrol Cosmetics Finance Conclusion AMOÉBA x SYNGENTA Signing of a Memorandum of Understanding with Syngenta for cereal crops Key aspects of the Memorandum of Understanding: ✓ Develop and market innovative biofungicide solutions, based on Amoeba's biofungicide active ing
Slide 12: And We Have a Potential Game-Changer…
Introduction Development Biocontrol Cosmetics Finance Conclusion AND WE HAVE A POTENTIAL GAME-CHANGER… Short-term development: An additional market segment to optimize the Launch of a biofertilizer innovation use of industrial equipment Promising initial results: 1 kg of active substance = 5 liters
Slide 13: The Potential of Biocontrol Is Only Beginning to Be Exploited
Introduction Development Biocontrol Cosmetics Finance Conclusion THE POTENTIAL OF BIOCONTROL IS ONLY BEGINNING TO BE EXPLOITED Agreement with Koppert: Vineyards and vegetable crops in 18 European countries and the United States MoU with Syngenta: Wheat in the European Union and the United Kingdom Ju
Slide 14: Skin Protection (Anti-ageing / Anti-UV)
Introduction Development Biocontrol Cosmetics Finance Conclusion SKIN PROTECTION (ANTI-AGEING / ANTI-UV) A recent and promising innovation with proven effects October 2023 - Remarkable in-vitro studies Anti-ageing effect Visible restoration of skin structure Anti-UV effect Young skin irradiated Youn
Slide 15: Skin Protection (Anti-ageing / Anti-UV)
Introduction Development Biocontrol Cosmetics Finance Conclusion SKIN PROTECTION (ANTI-AGEING / ANTI-UV) A recent and promising innovation with proven effects May 2024 – the clinical study Wrinkle reduction after 28 days confirms excellent in-vitro tests Results of clinical trials justifying very st
Slide 16: Amoéba x Oriental Beauty Valley
Introduction Development Biocontrol Cosmetics Finance Conclusion AMOÉBA x ORIENTAL BEAUTY VALLEY Signature of a contract with Metron Technology, a subsidiary of China's leading cosmetics company A strategic player in cosmetics in Two major objectives China ✓ On the regulatory front: approval of Amoé
Slide 17: Skin Protection (Anti-ageing / Anti-UV)
Introduction Development Biocontrol Cosmetics Finance Conclusion SKIN PROTECTION (ANTI-AGEING / ANTI-UV) A recent and promising innovation with proven effects 2023 2024 2025 2025-26 2026-27 Brevet INCI Label Cosmos Development Production & Filing of a patent to Inclusion of our cosmetic approved • B
Slide 18: A Major Reinforcement for the Amoéba Board
Introduction Development Biocontrol Cosmetics Finance Conclusion A MAJOR REINFORCEMENT FOR THE AMOÉBA BOARD A personality with multiple areas of expertise in the cosmetics and beauty industry Charlotte FRANCERIES A major player in the world of cosmetics and communication ✓ 25 years with the L'Oréal
Slide 19: A Company with Strong Support
Introduction Development Biocontrol Cosmetics Finance Conclusion A COMPAGNY WITH STRONG SUPPORT Shareholder structure Board of Directors following the capital increase (as of 23 July 2025) Benoit VILLERS Chairman Valérie LORENTZ-POINSOT Charlotte FRANCERIES Former CEO Laboratoires President of McCan
Slide 20: Shareholder's Notebook
Introduction Development Biocontrol Cosmetics Finance Conclusion SHAREHOLDER'S NOTEBOOK Share price on 28/11/2025: €0.965 Number of shares: 68,919,250 (24 July 2025) 4 research firms monitor Amoéba: Market capitalisation: €70 million Average daily volume Buy Buy Buy Hold 380,000 shares traded per da
Slide 21: Why Invest…
Introduction Development Biocontrol Cosmetics Finance Conclusion WHY INVEST … The only company in the world dedicated to amoeba culture Unique Technological Expertise Leadership Position ✓ The only company capable of cultivating an amoeba on ✓ Competitive advantages driven by unique specialization a
Slide 22: Amoéba amoeba-nature.com amoeba@actus.fr
Amoéba amoeba-nature.com amoeba@actus.fr
Slide 23: Disclaimer
DISCLAIMER References herein to this presentation (the “Presentation”) shall mean and include this document, any oral presentation accompanying this document provided by Amoeba SA (the “Company”), any question-and-answer session following that oral presentation and any further information that may b